These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3614989)

  • 1. American Leishmania spp: formycin B treatment of cutaneous leishmaniasis in mice.
    Rojas T; Avila JL
    Parasitology; 1987 Jun; 94 ( Pt 3)():467-74. PubMed ID: 3614989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57BL/6 mice.
    Avila JL; Rojas T; Monzón H; Convit J
    Am J Trop Med Hyg; 1990 Aug; 43(2):139-45. PubMed ID: 2389821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation and anti-leishmanial activity of formycin B.
    Carson DA; Chang KP
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1377-83. PubMed ID: 7271805
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism and mechanism of action of formycin B in Leishmania.
    Rainey P; Santi DV
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):288-92. PubMed ID: 6572004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental chemotherapy of leishmaniasis with adenosine analogue Formycin A, in combination with inhibitor of nucleoside transport, nitrobenzylthioinosinate.
    Ogbunude PO; al-Jaser MH
    Drugs Exp Clin Res; 1992; 18(10):423-6. PubMed ID: 1306154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster.
    Berman JD; Keenan CM; Lamb SR; Hanson WL; Waits VB
    Exp Parasitol; 1983 Oct; 56(2):215-21. PubMed ID: 6617804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026.
    Neal RA; Croft SL; Nelson DJ
    Trans R Soc Trop Med Hyg; 1985; 79(1):122-8. PubMed ID: 3992630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
    el-On J; Hamburger AD
    Trans R Soc Trop Med Hyg; 1987; 81(5):734-7. PubMed ID: 3449988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibitory effect of 3-deazaneplanocin A against several Leishmania mexicana and L. braziliensis strains.
    Avila JL; Avila A; Polegre MA; Marquez VE
    Am J Trop Med Hyg; 1997 Oct; 57(4):407-12. PubMed ID: 9347954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
    Grögl M; Oduola AM; Cordero LD; Kyle DE
    Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
    Berman JD; Rainey P; Santi DV
    J Exp Med; 1983 Jul; 158(1):252-7. PubMed ID: 6190980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of allopurinol ribonucleoside and formycin B on Trypanosoma cruzi infections in mice.
    Croft SL; Neal RA
    Trans R Soc Trop Med Hyg; 1985; 79(4):517-8. PubMed ID: 3936241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M; Thomason TN; Franke ED
    Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
    Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
    Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.
    Berman JD
    J Infect Dis; 1982 Feb; 145(2):279. PubMed ID: 6274970
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical genetic analysis of formycin B action in Leishmania donovani.
    Robinson N; Kaur K; Emmett K; Iovannisci DM; Ullman B
    J Biol Chem; 1984 Jun; 259(12):7637-43. PubMed ID: 6203896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice.
    Satoskar A; Al-Quassi HH; Alexander J
    Immunol Cell Biol; 1998 Apr; 76(2):159-66. PubMed ID: 9619486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.